SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TATRADER who wrote (300)8/4/1998 7:22:00 AM
From: Francois H. Gaston  Read Replies (1) of 857
 
Tatrader: I understand your points and you are making excellent ones!. It is true that the break out could be on the upside. What we are pretty sure of is that this stock will not stay in 8s...
For the news reported in last post:
''We are most pleased to announce the beginning of what should be a very conclusive study for treating very ill patients with this most devastating disease.'', I am a bit surprised that they do not spell out the number of patients they are going to enroll. 100? 1000? and did not name institutions, just locations. Are they that close to really enroll patients? Are they happy with the semi-quantification methods they will use, so as to prove efficacy?. I hope they are. Many studies have been botched in phase III in the past, despite "very promising preliminary results in early experiments". I agree: the potential is huge for HEB... hopefully the company will now execute this trial properly. Much easier said than done when placebo effects can be HUGE in this type of ailment (I.E.: control group could improve tremendously too, thereby "diminishing efficacy of drug in experimental group".
Good luck. But in my book, we are still in speculative phase for this drug. I hope it works, for patients and investors in HEB.
Good luck to all
FHG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext